129 related articles for article (PubMed ID: 12137761)
1. Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels.
Spada CS; Nieves AL; Woodward DF
Exp Eye Res; 2002 Aug; 75(2):155-63. PubMed ID: 12137761
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.
Mechiche H; Grassin-Delyle S; Robinet A; Nazeyrollas P; Devillier P
PLoS One; 2012; 7(9):e45273. PubMed ID: 22984630
[TBL] [Abstract][Full Text] [Related]
3. Excitatory action of prostanoids on the ferret isolated vagus nerve preparation.
Kan KK; Jones RL; Ngan MP; Rudd JA
Eur J Pharmacol; 2004 Apr; 491(1):37-41. PubMed ID: 15102531
[TBL] [Abstract][Full Text] [Related]
4. Characterization of prostanoid receptors present on adrenergic neurons innervating the porcine uterine longitudinal muscle.
Cao J; Nakamura T; Kitazawa T; Yamashiki N; Yamamoto T; Taneike T
Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):26-34. PubMed ID: 18403225
[TBL] [Abstract][Full Text] [Related]
5. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.
Senior J; Sangha R; Baxter GS; Marshall K; Clayton JK
Br J Pharmacol; 1992 Sep; 107(1):215-21. PubMed ID: 1422574
[TBL] [Abstract][Full Text] [Related]
7. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Shahbazian A; Heinemann A; Peskar BA; Holzer P
Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
[TBL] [Abstract][Full Text] [Related]
8. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Walsh MT; Kinsella BT
Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
[TBL] [Abstract][Full Text] [Related]
11. A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation.
Hu DN; McCormick SA; Woodward DF
Exp Eye Res; 2001 Jul; 73(1):93-100. PubMed ID: 11428866
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
Crankshaw DJ; Gaspar V
J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter.
Spada CS; Nieves AL; Burke JA; Wheeler LA; Woodward DF
J Ocul Pharmacol Ther; 2001 Jun; 17(3):255-77. PubMed ID: 11436946
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats.
Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K
Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response.
Woodward DF; Fairbairn CE; Goodrum DD; Krauss AH; Ralston TL; Williams LS
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():367-70. PubMed ID: 1825572
[No Abstract] [Full Text] [Related]
17. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
Sharif NA; Crider JY; Xu SX; Williams GW
J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Br J Pharmacol; 2003 Aug; 139(8):1409-16. PubMed ID: 12922927
[TBL] [Abstract][Full Text] [Related]
19. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
Verbeuren TJ; Vallez MO; Lavielle G; Bouskela E
Br J Pharmacol; 1997 Nov; 122(5):859-66. PubMed ID: 9384501
[TBL] [Abstract][Full Text] [Related]
20. RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.
Eglen RM; Whiting RL
J Pharm Pharmacol; 1989 May; 41(5):347-9. PubMed ID: 2569526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
